← FDA Drug Approvals (Drugs@FDA)

ACETAZOLAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2019-02-19

Drug application

FDA Application #
ANDA210423
Application type
Abbreviated New Drug Application (Generic)
Brand name
ACETAZOLAMIDE
Generic name
ACETAZOLAMIDE
Active ingredients
ACETAZOLAMIDE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing status
Prescription
Sponsor
ALEMBIC
Manufacturer
Alembic Pharmaceuticals Inc.
First approval
2019-02-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown